GM/CA's Mission
The GM/CA @ APS project was established
by the National Institute of General Medical Sciences
(NIGMS)
and the National Cancer Institute (NCI) of the National Institutes of Health
(NIH) to develop
and operate a national user facility for structure determination of
biological macromolecules by X-ray crystallography. Our mission is to
support challenging biomedical problems by providing a resource with
state-of-the-art synchrotron technology.
GM/CA provides beam time on a peer-reviewed basis to
the biological research community for investigations requiring advanced
synchrotron capabilities. The scientific and technical goals of the
GM/CA @ APS emphasize streamlined, efficient throughput for a variety
of sample types, sizes and qualities, representing the cutting edge of
structural biology research. The GM/CA @ APS facility offers X-ray
beams of exceptional stability and tunability, equipment to reliably
manipulate samples in the X-ray beam and record diffraction data, a
powerful biologist-friendly user interface, and a pipeline for data
processing with modern software.
|